12 查找结果 for "neoflex" 清空筛选
In the 2025 financial year, Datwyler generated revenue of CHF 1'100.5 million. Adjusted for negative currency effects of -3.7%, the company achieved organic growth of 3.1%. Due to these currency effects, reported revenue was overall 0.6% below the prior-year level.
Datwyler expanded its NeoFlex™ range of fully coated plungers with a solution for large-volume cartridges containing 20mL. The launch responds to rising demand for on-body devices for subcutaneous (SC) delivery of biotherapeutics to patients seeking convenient at-home care.
Datwyler announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group
德特威勒推出 NeoFlex™ 活塞，适用于大容量生物制剂的自动注射器和可穿戴式注射器。
德特威勒将为其注射剂包装即用型（Ready-to-Use, RTU）组件提供蒸汽灭菌的选项，蒸汽灭菌可保证药品2
Datwyler, a leading manufacturer of elastomer components for pharmaceutical packaging, recently completed three critical installations to support the safety of
Datwyler increased its revenue to CHF 1’101.7 million in 2021. Operating profit (EBIT) rose to CHF 234.2
Datwyler is expanding its production capacity with targeted investments and laying the foundation for further profitable growth.
Despite the ongoing uncertainty caused by the pandemic, Datwyler has increased its forecasts for the year as a whole for revenue and EBIT margin to over CHF 1’150 million and above 16%, respectively.
The company will also showcase NeoFlex™ plungers and DuraCoat™ combiseals, which enable drug developers to protect the integrity of injectables throughout development to distribution.
Unveiled at Pharmapack, the no-added silicone sealing solution mitigates contamination threats